Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-025097
Filing Date
2023-05-31
Accepted
2023-05-31 09:00:18
Documents
6

Document Format Files

Seq Description Document Type Size
1 DEFA14A fgen-defa14a-2023-supple.htm DEFA14A 70084
2 GRAPHIC img92467995_0.jpg GRAPHIC 93078
3 GRAPHIC img92467995_1.jpg GRAPHIC 66404
4 GRAPHIC img92467995_2.jpg GRAPHIC 359627
5 GRAPHIC img92467995_3.jpg GRAPHIC 77147
6 GRAPHIC img92467995_4.jpg GRAPHIC 57127
  Complete submission text file 0000950170-23-025097.txt   970752
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36740 | Film No.: 23979113
SIC: 2834 Pharmaceutical Preparations